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Abstract
Background: Little is known about the characteristics of people who do and do not agree to the
long-term storage and use of their biological materials, or about potential biases that may be
introduced as a result of differential consent. More specifically, concerns about tissue storage and
use are especially relevant among population groups for whom blood and other biological materials
are culturally significant, such as Indigenous Australians. Using data from a 2003–2005 study of
1,004 Indigenous Australians, we examined participants' choices regarding long-term storage of
excess blood for possible use in future studies.
Results: Overall, 55% of participants agreed to long-term storage. Among 854 participants with a
fasting blood sample and completed questionnaire, consent for storage was more likely among
those aged 45+ years than those 15–44 (odds ratio (OR) = 1.55, 95% confidence interval (CI): 1.14,
2.11), and was similar for males and females. After adjustment for age and other covariates using
logistic regression, consent was more likely for never smokers than current smokers (OR = 1.48,
95% CI: 1.04, 2.10), those reporting any non-Indigenous grandparent(s) (OR = 2.07, 95% CI: 1.50,
2.85), and those whose consent form was administered/witnessed by an Indigenous staff member
(OR 1.43, 95% CI: 1.05, 1.94). Consent for long-term storage was associated with only small
differences (generally less than ± 5%) in the results of assays performed on all participants' blood
samples as part of the baseline health examination.
Conclusion: These data show that consent for blood storage among these research participants
was neither rare nor universal. It was associated with some socio-demographic/cultural factors but
not with blood biochemistry. Decisions about requesting or giving consent for storage and later
use of tissue samples must recognize a number of important, and potentially competing, ethical and
logistical considerations.
Background
There has been concern about declining participation in
epidemiological studies, and possible reasons for this
decline [1,2]. The participation of minority groups in –
and their consequent ability to benefit from – research is
of particular interest to researchers as well as community
members [3,4]. Concurrently, researchers have continued
to reflect on how best to ensure ethical practice in health
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own sake, but also for more pragmatic reasons, such as
maintaining public support for research. The level of pub-
lic support can in turn affect a wide range of critical fac-
tors, from the level of government funding allocated for
research to the willingness of individuals to participate in
studies.
An area in which these two concerns about participation
and ethical practice have converged is the collection of
biological tissues from research participants and their
retention in a tissue bank for later use. The nature of such
future use is often unknown at the time of collection and
may include potentially sensitive applications such as
genetic testing [7,8]. The ethical challenges that arise, as
well as the potential for reduced participation and its neg-
ative consequences, may be especially relevant among
population groups for whom blood and other biological
materials are culturally significant, such as Indigenous
Australians [9].
Little is known about the characteristics of people who do
and do not agree to the long-term storage and use of their
biological materials, or about potential biases introduced
as a result of differential consent. In this paper, we exam-
ine three issues using data from a study of Indigenous
Australian adults: 1) the relationship between consent to
store blood samples and consent for other aspects of the
study; 2) the socio-demographic and cultural characteris-
tics associated with consent to store blood samples; and
3) the likely implications of decisions regarding this con-
sent with respect to potential for bias in future studies
using stored samples.
Methods
Data were collected in 2003–2005 as part of the DRUID
Study, a study of diabetes and related conditions in urban
Indigenous adults in the Darwin, Australia region. Dar-
win, the capital of the Northern Territory, is a tropical port
city of approximately 100,000 people located on the
northern coast of Australia.
The study has been described in detail elsewhere [10].
Briefly, eligible participants were aged 15 years or more,
identified as Aboriginal and/or Torres Strait Islander, had
lived in a defined geographic region in the Darwin area for
at least 6 months, and did not live in an institutional
dwelling. Eligible participants who gave consent under-
went a health examination including collection of blood
and urine samples, clinical and anthropometric measure-
ments, and administration of questionnaires.
Consent for various aspects of the study
For legal and administrative reasons, participants were
asked to provide separate consent for various parts of the
study by marking yes or no for each of several questions
and then signing in the presence of a DRUID staff mem-
ber. In addition to being asked about components of the
Table 1: Relationship of consent to store blood with consent for other aspects of the study*. Among 1,004 urban Indigenous Australian 
research participants in 2003–2005.
Proportion who gave consent for 
study staff to:
Agreed to long-term storage (n = 
550) %
Did not agreed to long-term 
storage (n = 454) %
Total (n = 1,004) %
Contact family and friends to help 
find participant
96.6 85.5 91.5
Contact participant to discuss 
continuation of the study beyond 
five years
93.1 85.9 89.8
Access information from health 
care provider
92.9 84.6 89.1
Access information from local 
Registrar of Births, Deaths and 
Marriages and the National Death 
Index
94.6 81.5 88.6
Access information from 
pathology services
92.4 82.2 87.8
Access information from local 
Department of Health and 
Community Services
92.2 80.4 86.8
Contact participant to discuss 
other related studies
88.2 73.6 81.6
Access information from the sole 
local private hospital
85.3 69.6 78.2
Long-term storage of excess blood 
samples
--- --- 54.8
* p < 0.001 for all comparisons between those who did and did not consent.Page 2 of 11
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"measurement of your body size") and whether they
wanted results sent to a health care provider, participants
were asked to indicate what they wanted to have done
with their remaining blood (and urine) samples and
whether they agreed to allow study staff to access informa-
tion about them from other specified sources and to con-
tact family/friends/the participant under certain
conditions (see Table 1). Missing responses were coded as
non-consent.
With respect to blood samples remaining after the com-
pletion of all baseline tests that were described in the par-
ticipant information sheet, participants were asked to
choose one of three options:
• Destroy remaining samples;
• Store remaining samples, but contact the participant to
seek permission if a researcher wishes to use them in
future;
• Store remaining samples, and use them without contact-
ing the participant, provided their use is approved by the
study's Indigenous Steering Group and relevant ethics
committee(s).
For the purposes of analysis, the second and third groups
were combined to create a dichotomous variable: store/
destroy.
As indicated in Figure 1, baseline blood tests were per-
formed for all participants who provided blood, regard-
less of whether they agreed to the subsequent storage of
any excess blood. All remaining blood samples from par-
ticipants who did not agree to long-term storage were
destroyed in late 2005. Blood samples for participants
who agreed to storage are currently stored in freezers (-
80C) at the Menzies School of Health Research in Darwin,
under the custody of the DRUID Study Project Leader
(JC). Any future use of these stored samples requires
application to the Project Leader as well as approval from
the Study's Management Group, its Indigenous Steering
Group, the relevant human research ethics committee(s),
and, for those who indicated that they wished to be con-
tacted prior to any use, the individual participants (or if
deceased, their next of kin). Should the relevant DRUID
Study groups cease to exist, the custody and/or disposal of
the stored samples will be determined by agreement
between the Project Leader and the Chair of the Indige-
nous Steering Group (TD), in consultation with the rele-
vant ethics committee(s).
Demographic, socioeconomic and cultural variables
Available demographic information included age, sex and
Indigenous status (whether identifies as Aboriginal only,
Torres Strait Islander only, or both Aboriginal and Torres
Strait Islander). Age was collected in whole years, and cat-
egorised for the purposes of analysis. Several different cat-
egories of age were assessed in preliminary analyses, but
two were used in the final analysis: 1) 10-year age groups
from 15–24 to 55–64 years, plus a category for age 65 and
over; and 2) a dichotomous variable indicating whether
the participant was aged 45 years or more (the maximum
age was 81 years).
Socio-economic variables available included the age at
which the participant left school, full-time employment
status, housing tenure and private health insurance.
Although information was collected on household
income and highest educational qualifications, these var-
iables were not included in the analysis due to a relatively
large number of missing values.
The age at which the participant left school was collected
using the following categories: still at school; never went
to school; under 14 years; 14 years; 15 years; 16 years; 17
years; and 18 years or over. Based on the distribution of
the data and the characteristics of the Australian educa-
tional system, data were combined to form three groups:
less than 14 years or never went to school; age 14–15
years; and age 16 or more years or still at school.
Data on full-time employment were taken from one of a
list of questions that were not mutually exclusive (e.g.
working full-time, part-time student, home duties). For
each item on the list, participants could respond "yes",
"no" or "don't know/not sure". Participants were classi-
fied as being in full-time employment if they responded
positively to the question on working full-time. Partici-
pants were classified as not being in full-time employ-
ment if they responded "no". Those who responded
"don't know/not sure" were coded as missing.
Housing tenure was collected using the following catego-
ries relating to the participant's current place of residence:
fully owned or being purchased by the participant or
someone in the household; being rented; being occupied
rent-free; and other: (please specify). Data were combined
into two categories for analysis: owned or being pur-
chased; and rented or other tenure.
Participants were considered to have private health insur-
ance if they indicated they had any of the following: hos-
pital cover only; extras cover only; both hospital and
extras cover; or private health insurance of a type
unknown to the participant. Participants were considered
not to have private health insurance if they respondedPage 3 of 11
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coded as missing.
Cultural variables included: whether the participant iden-
tifies with a clan, tribal or language group (yes/no);
whether has non-Indigenous grandparents (yes/no/don't
know); and whether identifies as a member or part of the
Stolen Generations (yes/no/prefer not to answer).
Responses of "don't know" or "prefer not to answer" were
coded as missing. The Stolen Generations is a term refer-
ring to Indigenous people who were forcibly removed
from their families as children by police or welfare officers
as part of government assimilation policies [11]. The lan-
guage for this potentially sensitive question was guided by
the study's Indigenous Steering Group.
Other variables included in the analysis were the Indige-
nous status of the staff member who witnessed the con-
sent form (Indigenous or non-Indigenous) and smoking
status (current, former or never smoker).
Baseline blood tests
A range of biochemical measures obtained from a fasting
blood sample were also available. Collection and analysis
methods have been described elsewhere [10]. These tests
were part of the baseline health examination and were
conducted for all participants who provided a fasting
blood sample, regardless of whether they consented to
long-term storage of excess samples.
Statistical methods
All analyses were performed using Stata version 9 (Stata
Corporation, College Station, TX). Pearson chi-squared
tests were used to assess the statistical significance of com-
parisons of the proportion of participants giving consent
to store blood with the proportions giving consent for
other study components. This analysis included all those
who completed a consent form and contributed any clin-
ical, biochemical, anthropometric or questionnaire data
(Figure 2). Simple and multiple logistic regression models
were used to assess the associations between selected
socio-economic, demographic and cultural variables and
the dependent variable of interest (consent to store
blood). Selection of variables for inclusion in the final
model in Table 2 began by including those variables most
strongly associated with the dependent variable, and sub-
sequently adding and deleting variables based on changes
in the fit of the model. Goodness of fit was assessed using
likelihood-ratio tests to compare nested models [12]; a
significance level of p < 0.10 was used for these tests. All
variables excluded from the final model were only weakly
associated with the dependent variable, with adjusted
odds ratios between 0.8 and 1.25. Ordinary least squares
regression models were used to estimate associations
between consent to store blood and baseline blood test
results, to assess the potential for selection bias in future
studies using stored samples. As blood test results were
not normally distributed, all values were natural log-
transformed prior to regression modelling, and geometric
rather than arithmetic means are presented. All logistic
and linear regression analyses were limited to participants
who provided a fasting blood sample and completed a
questionnaire (Figure 2).
Ethics approval
The study was approved by the Human Research Ethics
Committee of the Northern Territory Department of
Health & Community Services and Menzies School of
Health Research. It was considered and approved by both
the Aboriginal sub-committee, which has absolute right of
veto, and by the main committee. The study's governance
Participation in the DRUID StudyFigure 2
Participation in the DRUID Study.
DRUID Study recruitment
Completed 
consent 
form?
Provided 
fasting 
blood?
Provided 
any 
blood?
Completed 
Questionnaires
?
Provided 
data*?
Not included in study
Included in Table 1
n = 59
Included in Table 1
n = 70
No further analysis 
n = 5
Included in Table 1
n = 21
Included in all analyses
n = 854
Yes
(n = 1,009)
No
Yes (n = 1,004)
Yes (n = 945) Yes (n = 924) Yes
No
NoNo‡No†
* Includes any blood, urine, questionnaires, and/or anthropometric or clinical measurements.
† Most were not fasting at the time of screening and indicated that they would return another day to complete a fasting blood test, 
but failed to do so. Only 11 participants in this group did not give consent to have their blood taken. 
‡ Includes participants who indicated that they had consumed any food (other than chewing gum) or drinks (other than water or plain 
coffee or tea) within the 8 hours prior to testing. Usually this was a small snack or a sweet drink rather than a meal.
Flow chart of long-term blood storage in the DRUID Studyigure 1
Flow chart of long-term blood storage in the DRUID Study.
Completed 
consent 
form?
Agreed
to blood 
storage?
Provided 
blood?
Baseline tests 
performed
Blood stored
Provided 
blood?
Not included in study
Baseline tests
performed
No blood stored
No
No
No
No
Yes
Yes
Yes
YesPage 4 of 11
(page number not for citation purposes)
Epidemiologic Perspectives & Innovations 2007, 4:7 http://www.epi-perspectives.com/content/4/1/7
Table 2: Relationship of consent to store blood with selected socio-cultural, economic and demographic characteristics. Among 854 structure included an Indigenous Steering Group, as well
as partnerships with key Indigenous organisations [10].
Funding sources played no role in the study design, in the
collection, analysis and interpretation of the data, in the
writing of the manuscript, or in the decision to submit the
manuscript for publication. The corresponding author
had full access to all the data in the study, and had final
responsibility for the decision to submit for publication.
urban Indigenous Australian research participants who completed a questionnaire and provided a fasting blood sample in 2003–2005.
% of total % who agreed to 
long-term storage
Unadjusted 
model
Age-adjusted 
model
Final model†‡ (n = 770)
OR
*
95% CI* OR
*
95% CI* OR
*
95% CI*
Sex
Male 31.6 59.6 1.08 0.81, 1.45 1.10 0.82, 1.47
Female 68.4 57.7 1.0 --- 1.0 ---
Age group‡
15–44 71.0 55.3 1.0 --- --- 1.0 ---
45–81 29.0 65.7 1.55 1.14, 2.11 --- 1.49 1.04, 2.13
Indigenous group
Aboriginal only 83.6 56.7 1.0 --- 1.0 --- 1.0 ---
Torres Strait Islander only 5.8 70.0 1.78 0.96, 3.32 1.78 0.95, 3.33 1.85 0.96, 3.57
Both Aboriginal & Torres Strait Islander 10.5 64.4 1.38 0.88, 2.18 1.40 0.89, 2.22 1.59 0.97, 2.60
Age left school§
< 14 years or never went 5.4 56.5 0.99 0.54, 1.81 0.77 0.41, 1.46 0.84 0.42, 1.69
14–15 years 22.7 63.5 1.33 0.95, 1.86 1.18 0.84, 1.68 1.49 1.02, 2.18
≥ 16 years or still at school 71.9 56.7 1.0 --- 1.0 --- 1.0 ---
In full-time employment§
Yes 43.7 57.5 0.93 0.71, 1.23 0.94 0.71, 1.24
No 56.3 59.2 1.0 --- 1.0 ---
Housing tenure§
Owned or being purchased 42.5 61.3 1.24 0.94, 1.64 1.21 0.91, 1.60
Rented or other tenure 57.5 56.1 1.0 --- 1.0 ---
Private health insurance§
Yes 24.5 65.8 1.54 1.09, 2.16 1.50 1.06, 2.11
No 75.5 55.6 1.0 --- 1.0 ---
Smoking status§
Current smoker 43.5 52.2 1.0 --- 1.0 --- 1.0 ---
Former smoker 24.2 60.8 1.42 1.00, 2.01 1.35 0.95, 1.91 1.24 0.85, 1.80
Never smoker 32.3 64.0 1.63 1.18, 2.24 1.59 1.15, 2.20 1.48 1.04, 2.10
Identifies with clan, tribal, language group§
Yes 61.2 59.8 1.0 --- 1.0 ---
No 38.8 56.7 0.88 0.66, 1.17 0.94 0.71, 1.26
Has non-Indigenous grandparents§
Yes 69.3 63.8 1.90 1.40, 2.58 1.98 1.45, 2.70 2.07 1.50, 2.85
No 30.7 48.1 1.0 --- 1.0 --- 1.0 ---
Identifies as member of Stolen 
Generations§, ¶ 
Yes 27.1 63.6 1.34 0.96, 1.86 1.27 0.91, 1.77
No 72.9 56.7 1.0 --- 1.0 ---
Staff member who witnessed consent is 
Indigenous§
Yes 40.9 63.3 1.43 1.08, 1.89 1.36 1.02, 1.80 1.43 1.05, 1.94
No 59.1 54.8 1.0 --- 1.0 --- 1.0 ---
* OR, odds ratio; CI, confidence interval. Both were obtained from a logistic regression model.
† Includes all factors for which an estimate is shown.
‡ Similar results were obtained using 10-year age groups.
§ N = 854 except as indicated: age left school (n = 846); full-time employment (n = 836); housing tenure (n = 844); private health insurance (n = 
775); smoking status (n = 842); identifies with clan, tribal or language group (n = 828); has non-Indigenous grandparents (n = 785); identifies as a 
member of the Stolen Generations (n = 760); Staff member who witnessed the consent is Indigenous (n = 853).
¶ A term referring to Indigenous people who were forcibly removed from their families as children by police or welfare officers as part of 
government assimilation policies [11].Page 5 of 11
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A total of 1,009 people completed a consent form. Of
1,004 participants who provided at least one measure-
ment, just over half (54.8 percent) gave permission for
long-term storage of excess samples. Of these, the major-
ity (58.2 percent) indicated that they wanted to be con-
tacted for their permission prior to any future use. Those
who actually provided a blood sample (n = 945) were
more than twice as likely to give consent for storage than
were those who did not provide a sample following the
consent process (56.5 percent versus 27.1 percent; p <
0.001).
Consent for long-term blood storage was less commonly
given than consent for other aspects of the study (Table 1).
Participants who agreed to allow their blood to be stored
were also more likely to agree to other aspects of the study,
such as allowing study staff to access information about
them from various service providers and government
agencies (Table 1).
Among those who provided a fasting blood sample and
completed a questionnaire (n = 854), consent for long-
term storage varied according to demographic, socioeco-
nomic and cultural factors (Table 2). Consent was more
likely among those aged 45 years or more (adjusted odds
ratio (OR) = 1.5), never smokers (OR = 1.5), those who
reported having at least one non-Indigenous grandparent
(OR = 2.1), those whose consent form was witnessed by
an Indigenous staff member (OR = 1.4), and those who
left school at age 14 or 15 years (OR = 1.5) (Table 2). Par-
ticipants who identified as Torres Strait Islander were
more likely to agree to have their blood stored than those
who identified as Aboriginal (OR = 1.9), although the 95
percent confidence interval was relatively wide. The rela-
tive odds of agreeing to storage were smaller (in the range
0.8–1.2) for other factors after adjusting for these varia-
bles. Results were similar using 10-year age groups rather
than a dichotomous variable for age with categories of
15–44 and 45–81 years.
Consent for long-term storage was not associated with
large differences in any biochemical measure examined,
either before or after adjusting for 10-year age group and
sex (Table 3). Compared with those who did not agree to
storage, adjusted mean values for those who agreed to
storage ranged from 9.7 percent lower for C-reactive pro-
tein to 8.7 percent higher for fasting insulin (among par-
ticipants with diabetes), with most differences within ± 5
percent (Table 3). Among those who agreed to storage,
prior blood test results were similar for those who did and
did not want to be contacted prior to future use (data not
shown).
Discussion
The results indicate that consent for long-term storage of
excess blood samples for possible use in future studies was
neither rare nor universal among these urban Aboriginal
and Torres Strait Islander research participants. Consent
for blood storage was strongly related to consent for other
study components, although it was the component for
which consent was least likely. It was associated with
some but not all of the socio-demographic and cultural
factors examined. Consent to store blood was not associ-
ated with substantial differences in previous blood test
results, which suggests that any bias resulting from future
use of stored samples is unlikely to be large, at least for
analyses of similar substances.
A few studies have examined people's willingness to allow
storage and use of their biological samples, with higher
proportions among research participants and patients
than among the general public. In one study of the general
public, 43 percent of respondents indicated they would be
willing both to donate blood for research "to find genes
that affect people's health" and to have their blood stored
for later use [[13]:20]. The impact on the results of an
explicit reference to genetic research is unclear. In a study
examining actual consent among research participants, 87
percent agreed to allow their samples to be used for future
research. Similarly high proportions were seen for
patients, family members and healthy volunteers,
although a lower proportion (75 percent) of African
American participants consented [14]. Other studies of
research participants and clinical patients have reported
similarly high levels of consent – much higher than in the
present study – for future use of stored samples [15,16].
In the present study, cultural factors appeared to play a
role in participants' decision-making. Although the exact
nature of that role remains highly speculative, differing
levels of trust – whether of institutions, processes, social
groups and/or individuals – may be a common factor. For
example, the greater likelihood of consent among those
whose witness was Indigenous may reflect increased trust
due to shared membership of a salient social group.
Higher levels of consent among participants with non-
Indigenous grandparents may reflect greater familiarity
with mainstream health services, and a possible reduction
in distrust of health-related institutions, including
research organisations. Shavers and colleagues have sug-
gested that lower research participation by African Ameri-
cans is related to their lower levels of trust of medical
research [4]. It is important to understand that "trust" is
not a binary variable; it is possible to have varying degrees
of trust, and to have trust in some things (or people) but
not others. Trust in one dimension does not necessarily
guarantee trust in other areas. In the present study, there
were a number of interactions and processes in which thePage 6 of 11
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member administering the consent form; trust in the
study staff collecting information, taking blood and/or
taking clinical measurements; trust in the researchers
named in the participant information materials; trust in
the various institutions involved in the study; trust that
blood samples and other participant information would
be handled appropriately and respectfully; trust that par-
ticipants' decisions about what should be done with
excess samples would be carried out; and trust that stored
samples would not be accessed in a way that might bring
harm to participants. The results of this study suggest that
there were varying degrees of trust relating to the storage
and future use of excess blood samples among partici-
Table 3: Relationship of consent to store blood samples with selected biochemical measurements. Among 854 urban Indigenous 
Australian research participants who completed a questionnaire and provided a fasting blood sample in 2003–2005.
Did not agree to long-term storage (n = 356) Agreed to long-term storage (n = 498)
n Geometric mean 95% CI Geometric mean 95% CI
Fasting glucose (mmol/L)
All participants 854 5.5 5.3, 5.6 5.6 5.5, 5.7
Participants with diabetes† 149 8.7 7.8, 9.7 8.4 7.8, 9.0
Participants without diabetes†‡ 548 5.0 4.9, 5.0 5.0 4.9, 5.0
Fasting insulin (mU/L)
All participants 853 9.4 8.7, 10.2 9.8 9.1, 10.4
Participants with diabetes† 148 13.8 11.0, 17.3 15.0 12.8, 17.6
Participants without diabetes†‡ 548 8.3 7.6, 9.1 8.0 7.5, 8.7
Total cholesterol (mmol/L) 849 4.9 4.8, 5.1 4.9 4.8, 5.0
HDL cholesterol (mmol/L) 849 1.1 1.1, 1.1 1.1 1.1, 1.2
LDL cholesterol (mmol/L) 813 3.0 2.9, 3.1 2.9 2.8, 3.0
Triglycerides (mmol/L) 849 1.5 1.4, 1.6 1.5 1.4, 1.5
Homocysteine (umol/L) 854 9.5 9.1, 9.9 9.4 9.1, 9.7
Fibrinogen (g/L) 829 3.7 3.5, 3.8 3.6 3.5, 3.8
Haemoglobin A1c (%) 843 5.5 5.4, 5.6 5.6 5.5, 5.7
C-reactive protein (mg/L) 848 3.2 2.8, 3.7 3.0 2.7, 3.4
Estimated percent difference in the mean associated with consent to store blood sample*
Crude Adjusted for age and sex
% difference 95% CI % difference 95% CI
Fasting glucose (mmol/L)
All participants 2.2 -1.4, 5.9 0.6 -2.8, 4.0
Participants with diabetes† -4.0 -15.0, 8.3 -1.3 -12.8, 11.6
Participants without diabetes†‡ 0.2 -1.3, 1.7 0.1 -1.4, 1.5
Fasting insulin (mU/L)
All participants 3.6 -6.7, 14.9 1.7 -8.3, 12.8
Participants with diabetes† 9.1 -16.6, 42.7 8.7 -17.3, 42.8
Participants without diabetes†‡ -3.5 -14.2, 8.4 -4.0 -14.4, 7.8
Total cholesterol (mmol/L) -1.7 -4.4, 1.2 -2.1 -4.7, 0.6
HDL cholesterol (mmol/L) 2.5 -1.4, 6.6 3.1 -0.7, 7.1
LDL cholesterol (mmol/L) -2.1 -6.0, 2.1 -2.4 -6.3, 1.6
Triglycerides (mmol/L) -3.6 -10.9, 4.3 -6.4 -12.9, 0.5
Homocysteine (umol/L) -1.0 -5.8, 4.1 -2.7 -7.2, 2.0
Fibrinogen (g/L) -0.1 -4.8, 4.8 -0.9 -5.5, 4.0
Haemoglobin A1c (%) 0.7 -1.9, 3.3 -0.7 -3.0, 1.6
C-reactive protein (mg/L) -6.4 -21.3, 11.3 -9.7 -23.1, 6.1
* Calculated as 100(eβ -1), using the relevant regression coefficient from a linear regression model with the dependent variable measured on the log 
scale.
† Participants were classified as having diabetes if they met any of the following criteria: 1) fasting plasma glucose ≥ 7.0 mmol/L; 2) 2-hour post-
glucose load plasma glucose ≥ 11.1 mmol/L; or 3) previously diagnosed as having diabetes and currently taking tablets and/or insulin for diabetes. 
Among participants who were not currently taking tablets and/or insulin for diabetes, impaired glucose tolerance (IGT) was considered present if 
fasting glucose was < 7.0 mmol/L and 2-hour glucose was ≥ 7.8 and < 11.1 mmol/L; impaired fasting glucose (IFG) was considered present if fasting 
glucose was ≥ 6.1 and < 7.0 mmol/L, and 2-hour glucose was less than 7.8 mmol/L.
‡ Excludes those with impaired fasting glucose or impaired glucose tolerance, or whose diabetic status could not be classified.Page 7 of 11
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destroyed, 32 percent allowing storage but requiring per-
mission for further use, and 23 percent agreeing to storage
and future use of samples provided their use was
approved by the study's Indigenous Steering Group. It is
notable that, even among this last group, there is a
requirement for community input and agreement. That is,
participants were not asked to trust the researchers to
decide unilaterally what could be done with excess sam-
ples, although they obviously needed to have sufficient
trust in the integrity of the researchers to expect that they
would follow the processes outlined in the consent form.
Participants who identified as Torres Strait Islanders were
more likely to agree to long term blood storage than those
who identified as Aboriginal, although the 95 percent
confidence interval was relatively wide. Whether this
reflects cultural differences is not known. It is important
to note that Aboriginal Australians are an extremely heter-
ogeneous group with respect to culture, language, and
tribal affiliation, as well as social and economic circum-
stances. Unfortunately, it was not possible in this study to
stratify the "Aboriginal" group into more meaningful sub-
groups, in part because almost 4 in 10 participants indi-
cated that they did not identify with a clan, tribal or lan-
guage group.
Smokers were less likely to agree to storage than non-
smokers. Indigenous Australians are about twice as likely
to smoke as non-Indigenous Australians, and smoking is
a major contributor to the ill health of Indigenous Austral-
ians [17]. Many Indigenous Australian groups used native
tobacco and similar plants prior to contact with Europe-
ans, and tobacco continues to play a ceremonial role in
some areas, especially in Northern Australia [18,19]. It has
been suggested that tobacco's role in ensuring social cohe-
sion may be greater among Indigenous Australians than
among other Australians [19], and that tobacco is now
"embedded in the sociability and exchange of everyday
life for thousands of Aborigines and Torres Strait Island-
ers" [[18]:120]. Thus smoking may represent a tension
between maintaining a healthy lifestyle and enhancing
one's social and cultural connectedness.
Blood has been described as carrying "a heavy cultural
freight" [[20]:3011]; it is "inherently powerful" and "a
topic of great cultural sensitivity" among at least some
Indigenous Australian groups [[9]:25–26]. Although it is
certain that some people did not participate in the study
because they did not wish to have blood taken, it is not
clear to what extent any blood-related non-participation
was due to cultural considerations rather than other fac-
tors such as an aversion to needles or "bad veins".
Despite such potential sensitivities, the collection of
blood was considered necessary to meet the main aims of
the DRUID Study. By contrast, the long-term storage of
blood was not essential, and the decision to proceed was
a considered one. There are widespread perceptions that
Indigenous Australians as a group have been "over-
researched", but relatively little is known about the health
and wellbeing of Indigenous people living in urban areas.
The DRUID Study was, to our knowledge, the first large
study of urban Indigenous adults ever undertaken in Aus-
tralia, and the potential to answer future research ques-
tions without imposing additional burdens on members
of the population was seen as attractive, albeit not without
ethical challenges.
Decisions about requesting or giving consent for storage
and later use of tissue samples must recognize the poten-
tial tension between two central ethical principles, namely
justice and respect [21]. Justice includes maximising the
usefulness of an individual's participation and sharing the
research burden equitably. Respect includes supporting
participants' ability to determine what happens with
information collected from or about them. Maximising
the scientific return for an individual's participation helps
maximise community research benefits, but collecting
biological materials may compromise participation,
thereby potentially introducing bias and ultimately limit-
ing a study's scientific value. In this study, we tried to take
both justice and respect for autonomy into account by
allowing retention of excess samples while giving partici-
pants a choice regarding their own samples. No informa-
tion was available on how participants made their
decision or on the criteria they used to determine whether
or not to provide consent; further investigation in this
area is warranted.
The ethical principle of respect for autonomy was clearly
an important consideration in this study. Autonomy,
defined as "the ability to make informed choices about
what should be done and how to go about doing it"
[[22]:53], is considered by Doyal and Gough to be one of
two basic universal needs that must be met to enable indi-
viduals to "flourish" as human beings [22]. The other
basic need is survival/physical health. Importantly, physi-
cal health and autonomy are considered to have equal pri-
ority and to apply across cultures. To the extent that health
research improves physical health, participation in
research could be viewed as being morally desirable.
However, according to this framework, any such action
could not be undertaken in a way that reduces autonomy
without compromising the ability to meet an individual's
basic needs.
A tension between justice and respect for autonomy is not
necessarily inevitable. In the Australian National HealthPage 8 of 11
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ethical conduct in Indigenous health research, these two
principles are framed as complementary rather than com-
peting. The NHMRC approach is based not on compli-
ance with prescriptive rules, but on six core values: spirit
and integrity; reciprocity; respect; equality; survival and
protection; and responsibility [23]. These values are
intended to guide researchers in establishing ethical rela-
tionships of trust with Indigenous communities. By facil-
itating the creation of meaningful opportunities for
Aboriginal and Torres Strait Islander people to contribute
to all facets of research, from identification of research pri-
orities to development and implementation of research
processes to analysis, interpretation and translation of
data, this type of approach has the potential to maximise
community benefit through both higher participation
and higher scientific return. Such an approach shifts the
focus away from the often paternalistic protection of "vul-
nerable" individuals towards a model of community part-
nership and inclusion [24,25]. In theory, cooperation and
collaboration between communities and researchers can
increase both the representation of "vulnerable" people in
research and their access to the benefits of that research. In
practice, most research involves unequal power relation-
ships [26]; although this can make the development of
true partnerships challenging, it is critical to find mutually
agreeable ways to overcome such obstacles.
The present study was undertaken in a context of ongoing
suspicion of the research enterprise on the part of many
Indigenous Australians and their community leaders.
Despite a shift over the past decade to greater Indigenous
control of and involvement in research (as exemplified by
the creation of the Indigenous-led Cooperative Research
Centre for Aboriginal Health [27] and the NHMRC's Abo-
riginal and Torres Strait Islander Health Forum [28]),
there continues to be a perception that Indigenous people
are subjected to research that does not address their needs
but which provides researchers with substantial benefits,
such as prestige, fame, employment, higher degrees, etc.
In such a context, researchers need to prove themselves
worthy of trust over a sustained period if they are to build
respectful and productive partnerships with communities.
However, the requirements of this long-term process may
compete with the research team's ability to meet the scien-
tific aims of a particular project in the shorter term. In the
present study, for example, we needed to balance auton-
omy against the risk of bias. Although we believed that it
was "right" to have participants decide what would hap-
pen to their excess blood samples, we could not be sure
whether such a process would result in a sufficient
number of stored samples to be useful in the future, nor
did we know whether consent for storage would be related
to blood biochemistry. Although it appears that we have
been reasonably fortunate in both respects, whether this is
an indicator of the "correctness" of the original decision
depends on one's underlying ethical approach.
As in other endeavours, what is "right" in research may be
determined on the basis of a variety of factors, such as
duties or rules, outcomes, the character of the people
involved, or on ethical principles, such as justice, respect
for autonomy, beneficence and non-maleficence [29].
Sponsors, researchers, community leaders and partici-
pants may operate using different ethical frameworks, and
this may be especially relevant in a cross-cultural setting
(although it could be argued that all research is cross-cul-
tural to a greater or lesser degree). Even within research
teams, more than one approach may be used concur-
rently, especially when multiple disciplines are involved,
such as in the present study. The resolution of conflict can
be difficult is such situations, even when the points of
contention are clearly articulated, which is not always the
case. When values are incommensurable – that is, when
there is no common standard by which to evaluate
options – it is not possible to make choices in a rational
way [30], and the resulting compromises may be less than
satisfactory to those involved.
The NHMRC guidelines on ethical conduct in Indigenous
health research do not specifically address the issue of tis-
sue storage and use, but they clearly indicate the responsi-
bility of researchers to "do no harm to Aboriginal and
Torres Strait Islander individuals or communities"
[[23]:16]. This language reflects another important ethical
consideration: the potential for harm – including stigma
and discrimination – to non-participants and to social
groups [7,8,31]. As part of working with the community
to anticipate and address potential harms [31], any future
use of stored samples must be considered and approved
by the DRUID Study's Indigenous Steering Group, as well
as relevant ethics committee(s), regardless of individual
participants' prior consent.
The potential for harm is only one side of the ethical equa-
tion, however; it must be assessed against the potential for
benefit, both to individuals and communities. As is the
case with harms, however, different stakeholders, such as
sponsors, researchers, community leaders and individual
participants, may have different views about whether
something is actually a benefit, and about the magnitude
and relevance of any such benefit.
There has been considerable discussion in recent years
about how to prevent exploitation in research, particularly
in relation to clinical research undertaken in developing
countries by researchers from developed countries. For
example, a Fair Benefits Framework has been developed
by researchers and ethicists as a means of assessing
whether the distribution of benefits is "fair" in relation toPage 9 of 11
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fairness and exploitation are relevant not only in the
developing world but also for research in marginalised
communities in developed countries, such as Indigenous
peoples. The World Health Organisation has developed a
guide to preparing research agreements between Indige-
nous peoples and research institutions; the aim of such
agreements is to ensure transparency, an appropriate bal-
ancing of interests, and a shared understanding of a range
of important issues, such rights, responsibilities and
expectations [33]. Although we did not have a formal
agreement in the present study, we tried to address what
we – the researchers and the Indigenous Steering Group –
considered to be the key issues of concern. For example,
the Steering Group was involved in the development of
study protocols and materials, in the recruitment and
selection of staff, and in the development and implemen-
tation of the recruitment strategy; we developed agreed
terms of reference for the Steering Group and the Chief
Investigators Group and had cross-membership on the
two groups to ensure communication and transparency;
and we attempted to provide benefits at several levels,
such as the provision of individual results and targeted
health information for all participants, employment and
training opportunities for local Indigenous people, and
the provision of a part-time diabetes educator for the local
Aboriginal community-controlled health service. Whether
such putative benefits were sufficient to prevent exploita-
tion in the context of this study remains an open question.
One of the challenges for researchers working with Indig-
enous communities is a commonly experienced lack of
clarity about what the relevant "community" is, and who
or what represents it. Indigenous communities are not
homogeneous entities that speak with one voice. To the
contrary, there are likely to be multiple perspectives and
competing interests within a given community, and it can
be difficult for researchers and research institutions to
determine the appropriate body with which to negotiate.
In Australia, as elsewhere, there are a large number of
Indigenous community controlled organisations, such as
Aboriginal Community Controlled Health Services,
which have valuable experience in representing the often
diverse and conflicting interests of the people they repre-
sent (although their representative status is not always
uncontested) and in interacting with outside agents. As a
result, such organisations are well-placed to be able to
broker agreements between researchers and communities.
However, because these organisations are often already
under-resourced, it may be necessary for research institu-
tions to provide practical support to enable them to
undertake an active role in research brokerage [34].
Conclusion
Consent for blood storage among these urban Indigenous
research participants was neither rare nor universal and
was associated with some but not all of the socio-demo-
graphic/cultural factors examined. Decisions about
requesting or giving consent for storage and later use of
tissue samples must recognize a number of important,
and potentially competing, ethical and logistical consider-
ations. Successfully negotiating the ethical maze is a chal-
lenging but critical element of research, especially that
involving disadvantaged groups, to whom the benefits of
research may not be obvious. Finding appropriate solu-
tions can not be done by researchers in isolation, but must
involve active community partnerships, building/main-
taining relationships of trust, and real sharing of power
and decision-making. Such an approach is time-consum-
ing, but it is increasingly essential, not only on ethical
grounds but on scientific grounds as well.
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